This bi-directional, multicentre study aims to assess multiparametric MRI Radiomics-based prediction model for identifying metastasis lymph nodes and prognostic prediction in breast cancer.
Sensitivity for prediction of lymph node metastasis and survival of currently available prognostic scores in limited. This study proposes to establish a deep learning algorithms of multiparametric MRI radiomics and nomogram for identifying lymph node metastasis and prognostic prediction of breast cancer. The study will investigate the relationship between the radiomics and the tumor microenvironment. The study includes the construction of multiparametric MRI radiomics-based prediction model and the validation of the prediction model.
Study Type
OBSERVATIONAL
Enrollment
1,500
As this is a patient registry, there are no interventions.
Tungwah Hospital of Sun Yat-Sen University
Dongguan, Guangdong, China
NOT_YET_RECRUITINGShunde hospital of southern medical university
Foshan, Guangdong, China
RECRUITINGSun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Disease free survival (DFS)
Disease free survival (DFS), which defined as the time from the diagnosis of breast cancer to the confirmed time of metastatic disease, or death due to any other cause.
Time frame: 5 years
The correlation of radiomics features and tumor microenvironment
Radiomics is a tool to analyze tumor microenvironment characteristics based on breast MRI images.
Time frame: baseline (Completed MRI data before biopsy,surgery,neoadjuvant and radiotherapy.)
Lymph node metastasis
The value of Radiomics of multiparametric MRI in predicting axillary lymph node metastasis.
Time frame: Baseline
Overall survival (OS)
The association between Radiomics of multiparametric MRI and overall survival (OS), which defined as the time from the beginning of diagnosis of breast cancer to the death with any causes.
Time frame: 5 years
Beast cancer specific motality (BCSM)
Defined as time between randomization and the time of death occur specific due to breast cancer
Time frame: 5 years
Recurrence free survival (RFS)
defined as time between randomization and the time of any recurrence of ipsilateral chest, breast, regional lymph node recurrence, distant metastases, or death occurred
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Zhongshan Ophthalmic Center, Sun Yat-Sen University
Guangzhou, Guangdong, China
NOT_YET_RECRUITINGSun Yat-Sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
RECRUITING